Vaccine undergoing phase 3 trial for HIV is
Correct Answer: AIDS VAX
Description: AIDSVAX is an experimental HIV vaccine that was developed originally at Genentech in San Francisco, California, and later tested by the VaxGen company, a Genentech offshoot. A repo published in the December 2009 New England Journal of Medicine on this Thailand clinical trial, also known as the RV144 trial, of the vaccine known as "ALVAC-AIDSVAX B/E" showed the combination treatment's efficacy ranging from 26.1 to 31.4%, which though far from optimal makes the combination AIDSVAX-Aventis vaccine one of the first impoant milestones in the world's struggle to produce a globally effective HIV vaccine. However, during the study seven paicipants were removed from the study when the results showed they had already been found with an HIV-1 infection at baseline, which changed the result from 26.1 to 31.4% vaccination efficacy. Ref: https://en.m.wikipedia.org/wiki/AIDSVAX
Category:
Social & Preventive Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now